Adam Bensalah, MS

Adam Bensalah provides chemistry, manufacturing, and controls (CMC) and regulatory support to the healthcare product industry.  He contributes to the authoring of CMC sections for a range of regulatory submissions, including New Drug Applications (NDAs), Investigational New Drug Applications (INDs), and Investigational Medicinal Product Dossiers (IMPDs).  Adam also prepares, publishes, and performs data accuracy reviews of electronic submissions to Health Authorities.  He has prior experience where he provided analytical expertise and regulatory support to advance the CMC development of investigational drug products.  Adam has an M.S. in Regulatory Science from Arizona State University, an M.S. in Chemistry from Boston College, and a B.S. in Chemistry from the University of Tulsa.